Aehr Test Systems
AEHR
$24.74 -2.98%
Exchange: NASDAQ | Sector: Technology | Industry: Semiconductors
Q2 2025
Published: Jan 13, 2025

Earnings Highlights

  • Revenue of $13.45M down 37.2% year-over-year
  • EPS of $-0.03 decreased by 116.5% from previous year
  • Gross margin of 40.1%
  • Net income of -1.03M
  • ""We see significant potential to expand our packaged part test and burn-in business in the rapidly growing AI semiconductor market with our ultra-high power Sonoma product line."" - Gayn Erickson
AEHR
Aehr Test Systems

Executive Summary

In the second quarter of fiscal 2025, Aehr Test Systems (NASDAQ: AEHR) reported revenues of $13.5 million, a 37% decline compared to $21.4 million in the same period last year. The decline is attributed to challenges in the silicon carbide market and a push towards diversification in AI and gallium nitride testing. Despite the decrease in revenue, significant operational advancements and customer engagement led to a notable increase in demand for their high-margin WaferPaks, accounting for 64% of total revenue this quarter.
Management is optimistic about future growth driven by the rapidly expanding AI semiconductor sector and successful market penetration efforts for new product lines, particularly AI processors, which they expect could comprise 40% of total revenue this fiscal year. The company remains cautious about the ongoing geopolitical and trade risks in the market, particularly in its dealings with China, where competitive pressures are escalating.

Key Performance Indicators

Revenue
Decreasing
13.45M
QoQ: 2.55% | YoY: -37.23%
Gross Profit
Decreasing
5.40M
40.14% margin
QoQ: -23.71% | YoY: -50.72%
Operating Income
Decreasing
-1.51M
QoQ: -1 051.57% | YoY: -127.67%
Net Income
Decreasing
-1.03M
QoQ: -255.76% | YoY: -116.88%
EPS
Decreasing
-0.03
QoQ: -252.86% | YoY: -116.52%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 14.09 -0.10 -15.1% View
Q3 2025 18.31 -0.02 +142.1% View
Q2 2025 13.45 -0.03 -37.2% View
Q1 2025 13.12 0.02 -36.4% View
Q4 2024 16.60 0.81 -25.5% View